The Your
Nov 20, 2026
HyperLocal Loop
The Your

Close to home. Always in the loop.

Jenks resident finds new targeted drug extends life and restores family time

Jenks, Oklahoma – When Josh Austin received a stage 4 pancreatic cancer diagnosis in August 2024, the prognosis seemed bleak. After a Whipple surgery and a short course of traditional chemotherapy, his doctors warned him that his chances of surviving five years were only about 20 percent.

Rather than surrender to that outlook, Austin pursued a clinical trial at OU Health Stephenson Cancer Center in Oklahoma City. The trial tested daraxonrasib, an oral targeted therapy marketed as Rasonque, which attacks a specific KRAS protein pathway that fuels pancreatic tumors.

How the drug works

Dr. Susanna Ulahannan, a gastrointestinal oncologist and director of the Phase I Clinical Trials Program, explained that KRAS acts like an accelerator for cancer cells. “If you block that accelerator, the cancer stops,” she said. Austin’s tumor carried the KRAS mutation, making him eligible for the study. He began taking the pill in August 2025 and, more than a year later, reports that his disease has not spread.

“From what I’ve seen, it is amazing because it hasn’t, it hasn’t spread,” Austin said. While he stresses the drug is not a cure, it has given him a quality of life that chemotherapy could not.

Trial results show promise

The RASolute 302 trial enrolled roughly 500 patients with advanced pancreatic cancer. Participants receiving daraxonrasib experienced a median overall survival of 13.2 months, compared with 6.7 months for those on standard chemotherapy. Tumor response rates were about 30 percent versus 11 percent for chemotherapy.

Dr. Ulahannan noted the findings were especially meaningful because progress in pancreatic‑cancer treatment has been limited for decades. “When this data was presented in June 2026, there were standing ovations and tears,” she recalled. The drug received FDA approval in August 2026 for certain advanced‑stage patients.

Impact on Austin’s family life

Beyond the statistics, Austin emphasizes the personal benefits. He now works full‑time, has the energy to pursue hobbies after work, and has been able to attend his two children’s college graduations, travel to Alaska and Costa Rica, and enjoy family vacations.

“Sometimes there’s a little bit of pressure to enjoy every minute because you feel like you’ve been given this gift, right? Of getting to live, live longer,” he said.

Side effects and ongoing care

Targeted therapies are not without drawbacks. Austin reports skin irritation and acne‑like reactions that sometimes require medication. Dr. Ulahannan says clinicians monitor patients closely and can prescribe creams or preventive drugs to manage side effects.

Austin continues regular imaging every two months and monthly appointments. So far, scans show minimal remaining disease and no new spread.

What this means for other patients

Ulahannan believes the success of daraxonrasib could open doors for further research, including testing the drug in earlier disease stages or in combination with other treatments. She urges patients to discuss clinical‑trial options with their doctors, noting that trials rely on volunteers to advance medical knowledge.

For families like the Austins, the breakthrough offers not just extra months, but the chance to share meaningful moments together—a testament to the power of innovative medicine and the importance of community support.


Original reporting: KTUL 8 (Sinclair) – local — read the source article.

OBBM Network Editorial Staff

[email protected]

Editorial team behind OBBM Network — independent, hyper-local journalism syndicated through HyperLocalLoop and OBBM Network TV.

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent News

Trending

Community News

Quick Start Deal

Turn Local Reach Into Real Leads

A monthly bundle that puts your business in front of local audiences across HyperLocal Loop and the OBBM Network — and delivers ready-to-contact buyers to your team.

$500 Per Month
What's Included
  • LeadEngine · 1,000 Contacts Verified, buyer-intent prospects in your market, delivered to your team
  • DataPulse · 1,000 Matches Identify and retarget anonymous visitors to your site
  • Banner Ads · 3 Cities Geo-targeted display placement across HyperLocal Loop in three cities
  • Video Commercial · 3 Cities Your commercial airs on the local OBBM channel in three cities
  • Audio · 10,000 Impressions Podcast ad impressions across the OBBM Network
  • Geo-Targeting City or regional targeting via AdServe
  • Real-Time Reporting Track campaign performance as it happens
Questions about any of this? Ask Ben →
Get Started
Secure checkout · Cancel anytime
Quick Start Deal

Get Loop-Ready in One Move

A low-commitment monthly bundle that keeps your business in front of local audiences across HyperLocal Loop and the OBBM Network.

$350 Per Month
What's Included
  • DataPulse · 1,000 Matches Identify and retarget anonymous visitors to your site
  • Banner Ads Geo-targeted display placement across HyperLocal Loop
  • Video Ad Airs on your Local OBBM Channel
  • Business Advertorial A featured sponsored article telling your story
Questions about any of this? Ask Ben →
Get Started
Secure checkout · Cancel anytime
§ 04 · Choose Your Package

Three levels. Up to 60% off.

Every Patriot Package is priced at over 40% off standard AdRevv list rates — and the discount deepens as you scale, up to 60% off at the Enterprise tier.

Tier I · Local
The Patriot
For local & regional brands launching with the network.
List Price: $835/mo
$500/mo
★ Save $335 — 40% Off
Monthly Allotment
  • Audio: 10,000Podcast impressions
  • Video: 10,000Streaming TV impressions
  • Banners: 50,000HyperLocal Loop geo-targeted banner impressions
  • DataPulse: First 1,000visitor matches included
  • City or regional geo-targeting via AdServe
  • Real-time campaign reporting
Start The Patriot
Tier III · National
The Enterprise
For national brands ready to dominate the network.
List Price: $5,065/mo
$2026/mo
★ Save $3,039 — 60% Off
Monthly Allotment
  • Audio: 14,000Podcast impressions
  • Video: 10,000Streaming TV impressions
  • Banners: 100,000HyperLocal Loop geo-targeted impressions
  • DataPulse: 5,000visitor matches included
  • LeadEngine: 20,000actionable buyer-intent contacts
  • Host Endorsements: 9podcast host-read spots
  • National geo-targeting + dedicated campaign manager
  • Priority creative production support
★ Bonus Included ★
Free 1-Year Freedom Chamber Membership
Faith, Family & Freedom business community at freedomchamber.net.
Start Enterprise

Need a custom configuration? Build your own package →